MedPath logo

CLARITYN-D 12HOUR REPETABS

Pharmacy Only
Drug type: Therapeutic
ATC code: R01BA52
Dosage form: TABLET, SUGAR COATED
Route of administration: ORAL
Active ingredient: PSEUDOEPHEDRINE SULPHATE; LORATADINE; LORATADINE; PSEUDOEPHEDRINE SULPHATE

Indications and usage

Clarityn-D® 12Hour Repetabs is indicated for the relief of symptoms associated with allergic rhinitis and the common cold including nasal congestion, sneezing, rhinorrhea, pruritus and lacrimation.

Clarityn-D® 12Hour Repetabs is recommended when both the antihistaminic properties of loratadine and the decongestant effect of pseudoephedrine sulfate are desired.

Contraindications

Clarityn-D® 12Hour Repetabs are contraindicated in patients who have shown hypersensitivity or idiosyncrasy to their components, to adrenergic agents or to other drugs of similar chemical structure. Clarityn-D® 12Hour Repetabs are also contraindicated in patients receiving MAO inhibitor therapy or within 2 weeks of discontinuing such treatment and in patients with narrow angle glaucoma, urinary retention, severe hypertension, severe coronary artery disease and hyperthyroidism.

Dosage and administration

Adults and Children 12 years of age and over: One Clarityn-D® 12Hour Repetabs tablet twice a day.

Registrant
BAYER (SOUTH EAST ASIA) PTE LTD
Approval Date
1992-11-06
Approval Number
SIN07282P
Manufacturer
SAG Manufacturing SLU
Licence Holder
BAYER (SOUTH EAST ASIA) PTE LTD